Clinical trial
Comparative Study of Remimazolam, Remimazolam Plus Flumazenil vs Propofol Anesthesia on Emergence Time in Elderly Patients Undergoing Hip Replacement: A Randomized, Double Blinded Controlled Study
NCT06513923 is registered in ClinicalTrials.gov with Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study of Remimazolam, Remimazolam Plus Flumazenil vs Propofol Anesthesia on Emergence Time in Elderly Patients Undergoing Hip Replacement: A Randomized, Double Blinded Controlled Study
- Lead sponsor
- Central South University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 1, 2023
- Completion date
- October 31, 2023
- Enrollment
- 136 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hip fracture